Cumberland Seeks To Block Perrigo's Generic Acetadote
Cumberland alleges that Perrigo is seeking to undermine Cumberland's business by looking for regulatory approval to market an Acetadote copy prior to the expiration of the original drug's underlying patent issued in April of this year, U.S. Patent Number 8,148,356, titled, "Acetylcysteine composition and uses therefore."
"Perrigo has knowledge of the '356 patent, and Perrigo's actions constitute knowing...
Already a subscriber? Click here to login